Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula

NARecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Tobacco Use Disorder
Interventions
DEVICE

low intensity focused ultrasound (LIFU)

"Low-intensity focused ultrasound (LIFU) provides an energy source with millimeter resolution that can be focused anywhere in the brain safely and effectively for non-invasive and transient neuromodulation. LIFU is an important advance and of great significance for brain-mapping efforts, diagnostics, and therapies in neuroscience and particularly promising for addiction therapy as it provides unprecedented non-surgical access to the brain regardless of depth.~Much lower intensities of focused ultrasound (LIFU) are used so that tissue damage does not occur, but neural activity can be modulated. LIFU utilizes acoustic energy at much lower levels to affect tissue by mechanical effects."

Trial Locations (1)

20422

RECRUITING

Veterans Affairs Medical Center, Washington D.C.

All Listed Sponsors
lead

Washington D.C. Veterans Affairs Medical Center

FED

NCT06405074 - Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula | Biotech Hunter | Biotech Hunter